{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:53:18Z","timestamp":1784605998428,"version":"3.55.0"},"reference-count":50,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2021,9,20]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Methotrexate (MTX) is a water-insoluble, anti-tumor agent, causes adverse effects like bone marrow suppression, chronic interstitial obstructive pulmonary disease, hepatotoxicity, leukopenia, interstitial pneumonitis and\nnephrotoxicity with slow drug release rate.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The present study was aimed for successfully incorporating of MTX into novel-targeted Pluronic (PEO-PPOPEO tri-block co-polymer) F127 polymeric micelles intended for intravenous administration with improved drug loading\nand sustained release behavior necessary to achieve better efficacy of MTX.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> MTX-loaded Pluronic F127 micelles were characterized for critical micelle concentration,\nparticle size and zeta potential, <jats:sup>1<\/jats:sup>H NMR, drug loading, encapsulation efficiency characterization, cell\nuptake, in vitro release study along with partition coefficient and solubilization thermodynamics.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The micellar formulation resulted in nano size 27.32\u00b11.43nm of PF127\/SDS, as compared to\nPluronic F127 micelles or PF127\/Phosphatidyl choline which were 30.52\u00b11.18nm and 154.35\u00b15.5nm in\nsize, respectively. The uptake of PF127\/SDS micellar formulation incorporating Rhodamine 123 in\nMCF7 cancer cells was found to be higher (84.25%) than PF127\/PC, PF127 and MTX i.e. 66.26%,\n73.59% and 53% respectively. The in vitro MTX release from PF127, PF127\/SDS and PF127\/PC polymeric\nmicelles formulations was observed to be 69%, 69.5% and 66% at 12 h whereas 80.89%,\n77.67% and 78.54% after 24 h, respectively and revealed a sustained release. MTX-loaded PF127\/SDS\nmicelles showed high partition coefficient and negative free energy of solubilization compared to PF127\nand PF127\/PC which signify self-assembly behavior and thermodynamic stability towards higher dissociation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> It was finally concluded that MTX-loaded PF127\/SDS micelles act as a potential anticancer\ndelivery system in comparison to PF127\/PC and PF127 to combat tumor cells by enhancing their cellular\nuptake targeting with sustained release pattern and reducing the thermodynamic instability. Thus,\nPF127\/SDS micellar formulation can provide a useful alternative dosage form for intravenous administration\nof MTX.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201817666200810110914","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T07:41:02Z","timestamp":1597131662000},"page":"794-804","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Self-Assemble Amphiphilic PEO-PPO-PEO Tri-Block Co-Polymeric Methotrexate Nanomicelles to Combat MCF7 Cancer Cells"],"prefix":"10.2174","volume":"18","author":[{"given":"Manoj Kumar","family":"Mishra","sequence":"first","affiliation":[{"name":"Shambhunath Institute of Pharmacy, Jhalwa, Prayagraj, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8453-0142","authenticated-orcid":true,"given":"Jitendra","family":"Gupta","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-8580","authenticated-orcid":true,"given":"Reena","family":"Gupta","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nano.2011.05.006","volume":"8","author":"Huynh L.","year":"2012","unstructured":"Huynh L.; Neale C.; Pom\u00e8s R.; Allen C.; Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery. Nanomedicine (Lond) 2012,8(1),20-36","journal-title":"Nanomedicine (Lond)"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0939-6411(99)00039-9","volume":"48","author":"Jones M.","year":"1999","unstructured":"Jones M.; Leroux, J. Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999,48(2),101-111","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/bjc.1991.190","volume":"63","author":"Seymour L.W.","year":"1991","unstructured":"Seymour L.W.; Ulbrich K.; Wedge S.R.; Hume I.C.; Strohalm J.; Duncan R.N.; -(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice. Br J Cancer 1991,63(6),859-866","journal-title":"Br J Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2174\/1567201812666150416154552","volume":"13","author":"Taymouri S.","year":"2016","unstructured":"Taymouri S.; Varshosaz J.; Hassanzadeh F.; Javanmard S.H.; Mahzouni P.; Pharmacokinetics, organ toxicity and antitumor activity of docetaxel loaded in folate targeted cholesterol based micelles. Curr Drug Deliv 2016,13(4),545-556","journal-title":"Curr Drug Deliv"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.2174\/1567201815666180209113735","volume":"15","author":"Vakilzadeh H.","year":"2018","unstructured":"Vakilzadeh H.; Varshosaz J.; Minaiyan M.; Pulmonary delivery of triptorelin loaded in pluronic based nanomicelles in rat model. Curr Drug Deliv 2018,15(5),630-640","journal-title":"Curr Drug Deliv"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","volume":"47","author":"Kataoka K.","year":"2001","unstructured":"Kataoka K.; Harada A.; Nagasaki Y.; Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001,47(1),113-131","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ddtec.2005.05.007","volume":"2","author":"Nishiyama N.","year":"2005","unstructured":"Nishiyama N.; Bae Y.; Miyata K.; Fukushima S.; Kataoka K.; Smart polymeric micelles for gene and drug delivery. Drug Discov Today Technol 2005,2(1),21-26","journal-title":"Drug Discov Today Technol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/12_025","volume":"193","author":"Nishiyama N.","year":"2006","unstructured":"Nishiyama N.; Kataoka K.; Nanostructured devices based on block copolymer assemblies for drug delivery: Designing structures for enhanced drug function. Adv Polym Sci 2006,193,67-101","journal-title":"Adv Polym Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1208\/pt070374","volume":"7","author":"Chaurasia M.","year":"2006","unstructured":"Chaurasia M.; Chourasia M.K.; Jain N.K.; Jain A.; Soni V.; Gupta Y.; Jain S.K.; Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. AAPS PharmSciTech 2006,7(3),74","journal-title":"AAPS PharmSciTech"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/156720108784911668","volume":"5","author":"Chaurasia M.","year":"2008","unstructured":"Chaurasia M.; Chourasia M.K.; Jain N.K.; Jain A.; Soni V.; Gupta Y.; Jain S.K.; Methotrexate bearing calcium pectinate microspheres: a platform to achieve colon-specific drug release. Curr Drug Deliv 2008,5(3),215-219","journal-title":"Curr Drug Deliv"},{"key":"ref=11","first-page":"1202","author":"Calabresi P.B.A.C.","year":"1991","unstructured":"Calabresi P.B.A.C.; The Pharmacological Basis of TherapeuticsL.S.  Goodman, A. sqGilman (Eds.); Macmillan: New York, 1991,1202"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1517\/17425247.2012.642362","volume":"9","author":"Khan Z.A.","year":"2012","unstructured":"Khan Z.A.; Tripathi R.; Mishra B.; Methotrexate: a detailed review on drug delivery and clinical aspects. Expert Opin Drug Deliv 2012,9(2),151-169","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/873653","volume":"2012","author":"Sharma A.","year":"2012","unstructured":"Sharma A.; Arora S.; Formulation and in vitro evaluation of ufasomes for dermal administration of methotrexate. ISRN Pharm 2012,2012","journal-title":"ISRN Pharm"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/s2175-97902018000417222","volume":"54","author":"Paradkar M.","year":"2018","unstructured":"Paradkar M.; Amin J.; Formulation development and evaluation of colon targeted delayed release methotrexate pellets for the treatment of colonic carcinoma. Braz J Pharm Sci 2018,54,1-12","journal-title":"Braz J Pharm Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.2147\/IJN.S133034","volume":"12","author":"Alekseeva A.A.","year":"2017","unstructured":"Alekseeva A.A.; Moiseeva E.V.; Onishchenko N.R.; Boldyrev I.A.; Singin A.S.; Budko A.P.; Shprakh Z.S.; Molotkovsky J.G.; Vodovozova E.L.; Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma. Int J Nanomedicine 2017,12,3735-3749","journal-title":"Int J Nanomedicine"},{"key":"ref=16","first-page":"217","volume":"6","author":"Dixit A.S.","year":"2014","unstructured":"Dixit A.S.; Kulkarni P.K.; Reddy S.C.; Methotrexate fast disintegrating tablet as a dosage form for dysphagia patients. Int J Pharm Pharm Sci 2014,6,217-225","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=17","first-page":"87","volume":"3","author":"Theodore E.A.","year":"2015","unstructured":"Theodore E.A.; Halith S.M.; Barish, Hepzi, F.R., Formulation and evaluation of niosomes encapsulated methotrexate. Asian J Res Biol Pharm Sci 2015,3,87-94","journal-title":"Asian J Res Biol Pharm Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1023\/A:1007529218802","volume":"17","author":"Li Y.","year":"2000","unstructured":"Li Y.; Kwon G.S.; Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm Res 2000,17(5),607-611","journal-title":"Pharm Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.biomaterials.2004.06.004","volume":"26","author":"Zhang Y.","year":"2005","unstructured":"Zhang Y.; Zhuo R.X.; Synthesis and drug release behavior of poly (trimethylene carbonate)-poly (ethylene glycol)-poly (trimethylene carbonate) nanoparticles. Biomaterials 2005,26(14),2089-2094","journal-title":"Biomaterials"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0168-3659(02)00058-5","volume":"81","author":"Kang H.","year":"2002","unstructured":"Kang H.; Kim J.D.; Han S.H.; Chang I.S.; Self-aggregates of poly(2-hydroxyethyl aspartamide) copolymers loaded with methotrexate by physical and chemical entrapments. J Control Release 2002,81(1-2),135-144","journal-title":"J Control Release"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.3390\/app9224961","volume":"9","author":"Rigon R.B.","year":"2019","unstructured":"Rigon R.B.; Fachinetti N.; Severino P.; Durazzo A.; Lucarini M.; Atanasov A.G.; Mamouni S.E.; Chorilli M.; Santini A.; Souto E.B.; Quantification of trans-resveratrol-loaded solid lipid nanoparticles by a validated reverse-phase HPLC photodiode array transferrin-conjugated docetaxel PLGA nanoparticles for tumor targeting: influence on MCF-7 cell cycle. Appl Sci (Basel) 2019,9,4961","journal-title":"Appl Sci (Basel)"},{"key":"ref=22","first-page":"1","volume":"Vol. 1","author":"Campos J.R.","year":"2020","unstructured":"Campos J.R.; Severino P.; Santini A.; Silva A.M.; Shegokar R.; Souto S.B.; Souto E.;  Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical propertiesNanopharmaceuticals Expectations and reality of multifunctional drug delivery systems 2020,Vol. 1,1-17","journal-title":"Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical propertiesNanopharmaceuticals Expectations and reality of multifunctional drug delivery systems"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/pharmaceutics12020146","volume":"12","author":"Souto E.B.","year":"2020","unstructured":"Souto E.B.; Silva G.F.; Dias-Ferreira J.; Zielinska A.; Ventura F.; Durazzo A.; Lucarini M.; Novellino E.; Santini A.; Nanopharmaceutics: Part I-Clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU. Pharmaceutics 2020,12(2),146","journal-title":"Pharmaceutics"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/nano10030455","volume":"10","author":"Souto E.B.","year":"2020","unstructured":"Souto E.B.; Silva G.F.; Dias-Ferreira J.; Zielinska A.; Ventura F.; Durazzo A.; Lucarini M.; Novellino E.; Santini A.; Nanopharmaceutics: Part II-Production scales and clinically compliant production methods. Nanomaterials (Basel) 2020,10(3),455","journal-title":"Nanomaterials (Basel)"},{"key":"ref=25","first-page":"157","volume":"4","author":"Souto E.B.","year":"2020","unstructured":"Souto E.B.;  In: Drug Delivery Aspects, Shegokar R. (ed.). Expectations and realities of multifunctional drug delivery systems; Elsevier (Amsterdam, Netherlands) 2020,4,157-168"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1021\/ja807416t","volume":"131","author":"Griset A.P.","year":"2009","unstructured":"Griset A.P.; Walpole J.; Liu R.; Gaffey A.; Colson Y.L.; Grinstaff M.W.; Expansile nanoparticles: Synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system. J Am Chem Soc 2009,131(7),2469-2471","journal-title":"J Am Chem Soc"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-69290-1_67","author":"Dembinski T.C.","year":"1983","unstructured":"Dembinski T.C.; Green C.D.;  Regulation of oestrogen responsiveness of MCF-7 human breast cancer cell growth by serum concentration in the culture medium 1983","journal-title":"Regulation of oestrogen responsiveness of MCF-7 human breast cancer cell growth by serum concentration in the culture medium"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/0039-128X(75)90110-5","volume":"26","author":"Horwitz K.B.","year":"1975","unstructured":"Horwitz K.B.; Costlow M.E.; McGuire W.L.; MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids 1975,26(6),785-795","journal-title":"Steroids"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.addr.2011.05.016","volume":"63","author":"Kaminskas L.M.","year":"2011","unstructured":"Kaminskas L.M.; Porter C.J.; Targeting the lymphatics using dendritic polymers (dendrimers). Adv Drug Deliv Rev 2011,63(10-11),890-900","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11095-011-0510-x","volume":"29","author":"Chaudhari K.R.","year":"2012","unstructured":"Chaudhari K.R.; Ukawala M.; Manjappa A.S.; Kumar A.; Mundada P.K.; Mishra A.K.; Mathur R.; M\u00f6nkk\u00f6nen J.; Murthy R.S.R.; Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier. Pharm Res 2012,29(1),53-68","journal-title":"Pharm Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1021\/mp2002939","volume":"9","author":"Letchford K.","year":"2012","unstructured":"Letchford K.; Burt H.M.; Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics. Mol Pharm 2012,9(2),248-260","journal-title":"Mol Pharm"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","volume":"130","author":"Batrakova E.V.","year":"2008","unstructured":"Batrakova E.V.; Kabanov A.V.; Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008,130(2),98-106","journal-title":"J Control Release"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-5173(95)04386-1","volume":"132","author":"Zhang X.","year":"1996","unstructured":"Zhang X.; Jackson J.K.; Burt H.M.; Development of amphiphilic diblock copolymers as micellar of taxol. Int J Pharm 1996,132,195-206","journal-title":"Int J Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1021\/la9709655","volume":"14","author":"Lopes J.R.","year":"1998","unstructured":"Lopes J.R.; Loh W.; Investigation of self-assembly and micelle polarity for a wide range of ethylene oxide propylene oxide ethylene oxide block copolymers in water. Langmuir 1998,14,750-756","journal-title":"Langmuir"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijpharm.2009.04.030","volume":"376","author":"Wei Z.","year":"2009","unstructured":"Wei Z.; Hao J.; Yuan S.; Li Y.; Juan W.; Sha X.; Fang X.; Paclitaxel-loaded Pluronic P123\/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm 2009,376(1-2),176-185","journal-title":"Int J Pharm"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/j.biomaterials.2009.11.102","volume":"31","author":"Mu C.F.","year":"2010","unstructured":"Mu C.F.; Balakrishnan P.; Cui F.D.; Yin Y.M.; Lee Y.B.; Choi H.G.; Yong C.S.; Chung S.J.; Shim C.K.; Kim D.D.; The effects of mixed MPEG-PLA\/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials 2010,31(8),2371-2379","journal-title":"Biomaterials"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijpharm.2007.06.044","volume":"344","author":"Vroman B.","year":"2007","unstructured":"Vroman B.; Ferreira I.; J\u00e9r\u00f4me C.; J\u00e9r\u00f4me R.; Pr\u00e9at V.; PEGylated quaternized copolymer\/DNA complexes for gene delivery. Int J Pharm 2007,344(1-2),88-95","journal-title":"Int J Pharm"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.colsurfb.2009.03.027","volume":"72","author":"Kadam Y.","year":"2009","unstructured":"Kadam Y.; Yerramilli U.; Bahadur A.; Solubilization of poorly water-soluble drug carbamezapine in pluronic micelles: effect of molecular characteristics, temperature and added salt on the solubilizing capacity. Colloids Surf B Biointerfaces 2009,72(1),141-147","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0168-3659(01)00299-1","volume":"73","author":"Torchilin V.P.","year":"2001","unstructured":"Torchilin V.P.; Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001,73(2-3),137-172","journal-title":"J Control Release"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1517\/17425247.3.1.139","volume":"3","author":"Aliabadi H.M.","year":"2006","unstructured":"Aliabadi H.M.; Lavasanifar A.; Polymeric micelles for drug delivery. Expert Opin Drug Deliv 2006,3(1),139-162","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1021\/la010004x","volume":"17","author":"Li Y.","year":"2001","unstructured":"Li Y.; Xu R.; Couderc S.; Bloor D.M.; Holzwarth J.F.; Wyn-Jones E.; Binding of tetradecyltrimethylammonium bromide to the ABA block copolymer pluronic F127 (EO 97 PO 69 EO 97): Electromotive force, microcalorimetry, and light scattering studies. Langmuir 2001,17,5742-5747","journal-title":"Langmuir"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0168-3659(03)00211-6","volume":"91","author":"Kabanov A.V.","year":"2003","unstructured":"Kabanov A.V.; Batrakova E.V.; Alakhov V.Y.; An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J Control Release 2003,91(1-2),75-83","journal-title":"J Control Release"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1515\/polyeng-2016-0228","volume":"38","author":"Ye W.","year":"2018","unstructured":"Ye W.; Zhu L.; Xia S.; Zhang X.; Dual pH-\/temperature-responsive and fluorescent hydrogel for controlled drug delivery. J Polymer Eng 2018,38,371-379","journal-title":"J Polymer Eng"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"11658","DOI":"10.1038\/s41598-019-48254-6","volume":"9","author":"Chatterjee S.","year":"2019","unstructured":"Chatterjee S.; Hui P.C.; Kan C.W.; Wang W.; Dual-responsive (pH\/temperature) Pluronic F-127 hydrogel drug delivery system for textile-based transdermal therapy. Sci Rep 2019,9(1),11658","journal-title":"Sci Rep"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/(SICI)1097-0320(19971201)29:4<279:AID-CYTO3>3.0.CO;2-5","volume":"29","author":"Krishan A.","year":"1997","unstructured":"Krishan A.; Fitz C.M.; Andritsch I.; Drug retention, efflux, and resistance in tumor cells. Cytometry 1997,29(4),279-285","journal-title":"Cytometry"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","volume":"82","author":"Kabanov A.V.","year":"2002","unstructured":"Kabanov A.V.; Batrakova E.V.; Alakhov V.Y.; Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002,82(2-3),189-212","journal-title":"J Control Release"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1021\/bc950093n","volume":"7","author":"Alakhov V.Yu.","year":"1996","unstructured":"Alakhov V.Yu.; Moskaleva EYu; Batrakova, E.V.; Kabanov, A.V. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug Chem 1996,7(2),209-216","journal-title":"Bioconjug Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","volume":"54","author":"Kabanov A.V.","year":"2002","unstructured":"Kabanov A.V.; Batrakova E.V.; Alakhov V.Y.; Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 2002,54(5),759-779","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"17343","DOI":"10.1016\/S0021-9258(18)71498-1","volume":"264","author":"Ishikawa T.","year":"1989","unstructured":"Ishikawa T.; ATP\/Mg2+-dependent cardiac transport system for glutathione S-conjugates. A study using rat heart sarcolemma vesicles. J Biol Chem 1989,264(29),17343-17348","journal-title":"J Biol Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0168-3659(00)00358-8","volume":"71","author":"Zauner W.","year":"2001","unstructured":"Zauner W.; Farrow N.A.; Haines A.M.R.; In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release 2001,71(1),39-51","journal-title":"J Control Release"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184722\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T10:58:50Z","timestamp":1638701930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184722\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,9,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201817666200810110914","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}